A few years later, mutations in the leucine-rich repeat kinase 2 (LRRK2) gene were found to exhibit significant impact across familial and sporadic PD (Paisan-Ruiz et al., 2004; Zimprich et al., 2004). This evidence concerns the gene LRRK2 and Parkinson disease.